To this aim, we performed immunofluorescent stainings for CD8, CD161, and TCR Vα7.2 on post-mortem brain tissues from 15 progressive MS cases, selected for the presence of conspicuous inflammatory infiltrates both in the subarachnoid spaces and in active and chronic active WM lesions. The gene discussed is CD8A; the disease is myeloid sarcoma.